"The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission tomography (PET) imaging of the brain in adults being evaluated for Alzheimer's disease (AD) "...
Razadyne ER Patient Information including How Should I Take
In this Article
- What is galantamine (Razadyne ER)?
- What are the possible side effects of galantamine (Razadyne ER)?
- What is the most important information I should know about galantamine (Razadyne ER)?
- What should I discuss with my healthcare provider before taking galantamine (Razadyne ER)?
- How should I take galantamine (Razadyne ER)?
- What happens if I miss a dose (Razadyne ER)?
- What happens if I overdose (Razadyne ER)?
- What should I avoid while taking galantamine (Razadyne ER)?
- What other drugs will affect galantamine (Razadyne ER)?
- Where can I get more information?
What should I discuss with my healthcare provider before taking galantamine (Razadyne ER)?
You should not use galantamine if you are allergic to it.
To make sure you can safely take galantamine, tell your doctor if you have any of these other conditions:
- urination problems;
- heart disease or a heart rhythm disorder;
- a history of stomach ulcer or bleeding;
- seizures or epilepsy;
- kidney disease;
- liver disease; or
- a history of asthma or chronic obstructive pulmonary disease (COPD).
FDA pregnancy category B. Galantamine is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether galantamine passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I take galantamine (Razadyne ER)?
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Your doctor may occasionally change your dose to make sure you get the best results.
The galantamine extended-release capsule is usually taken once per day in the morning. Follow your doctor's instructions.
The galantamine short-acting tablet or the oral solution (liquid) are usually given two times per day, with meals. Follow your doctor's instructions.
The extended-release capsule works best if you take it with food.
Do not crush, chew, break, or open an extended-release capsule. Swallow it whole. Breaking or opening the pill may cause too much of the drug to be released at one time.
Measure the liquid using only the special dose-measuring device provided. Empty the medicine into 3 to 4 ounces of any non-alcoholic beverage. Stir this mixture and drink all of it right away. Rinse the dose-measuring device with water after each use.
The liquid form of this medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.
Take galantamine with a full glass of water. Drink 6 to 8 full glasses of water each day to keep from getting dehydrated while taking this medication.
If you need surgery, tell the surgeon ahead of time that you are using galantamine. You may need to stop using the medicine for a short time.
If you have stopped taking galantamine for any reason, talk with your doctor before you start taking it again. You may need to restart the medication at a lower dose.
Store at room temperature away from moisture and heat. Do not allow the liquid medicine to freeze.
Additional Razadyne ER Information
- Razadyne ER Drug Interactions Center: galantamine oral
- Razadyne ER Side Effects Center
- Razadyne ER Overview including Precautions
- Razadyne ER FDA Approved Prescribing Information including Dosage
Razadyne ER - User Reviews
Razadyne ER User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.